UNIC I&I: About Us

UNIC aims to identify the infectious aetiology of human cancer. UNIC’s main study area is human papillomavirus (HPV) and related diseases. At UNIC, many studies focus on understanding the burden, natural history and prevention of diseases related to HPV. Working alongside the UNIC laboratory, one of the primary activities is the identification of HPV in major international tumour series in order to describe the global distribution of HPV genotypes.

UNIC is also involved in research projects studying infectious, hormonal and genetic risk factors of lymphomas, chronic lymphocytic leukaemia and multiple myeloma while the Information Centre takes part in numerous multicentre case-control studies such as MCC Spain, EPILYMPH, ICGC-CLL and InterLymph consortiums. UNIC manages and oversees protocol coordination, the follow-up and evaluation of cervical cancer detection activities within primary healthcare centres in Catalonia.

Primary research areas:

  • Genital cancer and human papillomavirus (HPV) studies and prevention through specific vaccines.
  • Aetiological studies of infectious malignant lymphomas.
  • Studies of infectious, genetic and environmental risk factors linked to the development of lymphomas.
  • Genetic susceptibility and the interaction between genes and environment.
  • Aetiological studies of cervical cancer, oral cancer, throat cancer, laryngeal cancer, vaginal cancer, vulvar cancer, penile cancer and anal cancer.
  • Research in areas of modelling and economic evaluation of cancer prevention measures in Spain and other countries. Prostate cancer studies (under preparation).
  • ICO Information Centre for HPV and related diseases.
  • Development of logistical instruments for the coordination and dissemination of information about the virus and cancer.
  • Cervical cancer screening and prevention.
  • Clinical trials of vaccines against HPV and evaluation of the impact of the HPV vaccine programmes.